Related Experiment Video
Updated: Jan 30, 2026

Hepatic Progenitor Specification from Pluripotent Stem Cells using a Defined Differentiation System
Published on: May 10, 2020
Hepatic carboxylesterases are differentially regulated in PPARα-null mice treated with perfluorooctanoic acid
Xia Wen1, Angela A Baker1, Curtis D Klaassen2
1Department of Pharmacology and Toxicology, Rutgers University Ernest Mario School of Pharmacy, Piscataway, NJ, 08854, USA.
Abstract:
Hepatic carboxylesterases (Ces) catalyze the metabolism of drugs, environmental toxicants, and endogenous lipids and are known to be regulated by multiple nuclear receptors. Perfluorooctanoic acid (PFOA) is a synthetic fluorochemical that has been associated with dyslipidemia in exposed populations. In liver, PFOA can activate nuclear receptors such as PPARα, and alter the metabolism and excretion of chemicals. Here, we sought to test the ability of PFOA to modulate Ces expression and activity in the presence and absence of the PPARα receptor. For this purpose, male C57BL/6 NCrl mice were administered PFOA (1 or 3 mg/kg, po, 7 days) and livers collected for assessment of Ces expression and activity. PFOA increased Ces1 and 2 protein and activity. Notably, PFOA increased Ces1d, 1e, 1f, 1 g, 2c, and 2e mRNAs between 1.5- and 2.5-fold, while it decreased Ces1c and 2b. Activation of PPARα by PFOA was confirmed by up-regulation of Cyp4a14 mRNA. In a separate study of PFOA-treated wild-type (WT) and PPARα-null mice, induction of Ces 1e and 1f mRNA and in turn, Ces1 protein, was PPARα-dependent. Interestingly, in PPARα-null mice, Ces1c, 1d, 1 g, 2a, 2b, and 2e mRNAs and Ces2 protein were up-regulated by PFOA which contributed to sustained up-regulation of Ces activity, although to a lower extent than observed in WT mice. Activation of the CAR and PXR receptors likely accounted for up-regulation of select Ces1 and 2 subtypes in PPARα-null mice. In conclusion, the environmental contaminant PFOA modulates the expression and function of hepatic Ces enzymes, in part through PPARα.
Insights
The environmental contaminant perfluorooctanoic acid (PFOA) alters liver enzyme expression and activity, impacting drug metabolism. This modulation occurs partly through the PPARα receptor, affecting how the body processes chemicals.
Area of Science:
- Biochemistry
- Toxicology
- Pharmacology
Background:
- Hepatic carboxylesterases (Ces) are crucial for metabolizing xenobiotics and endogenous lipids.
- Nuclear receptors, including PPARα, regulate Ces expression and activity.
- Perfluorooctanoic acid (PFOA), a widespread environmental contaminant, is linked to dyslipidemia and can activate PPARα.
Purpose of the Study:
- To investigate the effect of PFOA on hepatic Ces expression and activity.
- To determine the role of the PPARα receptor in PFOA-mediated modulation of Ces.
Main Methods:
- Administration of PFOA to male C57BL/6 NCrl mice (wild-type and PPARα-null).
- Assessment of Ces mRNA, protein, and activity in liver tissues.
- Confirmation of PPARα activation via Cyp4a14 mRNA levels.
Main Results:
- PFOA significantly increased Ces1 and Ces2 protein and activity in wild-type mice.
- PFOA modulated the expression of various Ces1 and Ces2 mRNA subtypes in a PPARα-dependent manner.
- In PPARα-null mice, PFOA still induced certain Ces subtypes, suggesting involvement of other nuclear receptors like CAR and PXR.
Conclusions:
- PFOA alters hepatic Ces expression and activity, contributing to its toxicological effects.
- PPARα is a key mediator of PFOA's effects on Ces, but other pathways also contribute.
- Understanding these mechanisms is vital for assessing PFOA's health risks.
Related Concept Videos
Master Transcription Regulators
Respiratory Regulation of Acid-Base Balance
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

